Unknown

Dataset Information

0

Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.


ABSTRACT: The highly polymorphic human leukocyte antigen (HLA) class I molecules present peptide antigens to CD8+ T cells, inducing immunity against infections and cancers. Quality control mediated by peptide loading complex (PLC) components is expected to ensure the cell surface expression of stable peptide-HLA class I complexes. This is exemplified by HLA-B*08:01 in primary human lymphocytes, with both expression level and half-life at the high end of the measured HLA-B expression and stability hierarchies. Conversely, low expression on lymphocytes is measured for three HLA-B allotypes that bind peptides with proline at position 2, which are disfavored by the transporter associated with antigen processing. Surprisingly, these lymphocyte-specific expression and stability differences become reversed or altered in monocytes, which display larger intracellular pools of HLA class I than lymphocytes. Together, the findings indicate that allele and cell-dependent variations in antigen acquisition pathways influence HLA-B surface expression levels, half-lives and receptivity to exogenous antigens.

SUBMITTER: Yarzabek B 

PROVIDER: S-EPMC6039183 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Yarzabek Brogan B   Zaitouna Anita J AJ   Olson Eli E   Silva Gayathri N GN   Geng Jie J   Geretz Aviva A   Thomas Rasmi R   Krishnakumar Sujatha S   Ramon Daniel S DS   Raghavan Malini M  

eLife 20180710


The highly polymorphic human leukocyte antigen (HLA) class I molecules present peptide antigens to CD8<sup>+</sup> T cells, inducing immunity against infections and cancers. Quality control mediated by peptide loading complex (PLC) components is expected to ensure the cell surface expression of stable peptide-HLA class I complexes. This is exemplified by HLA-B*08:01 in primary human lymphocytes, with both expression level and half-life at the high end of the measured HLA-B expression and stabili  ...[more]

Similar Datasets

2023-04-03 | GSE228593 | GEO
| PRJNA950409 | ENA
| S-EPMC2887091 | biostudies-literature
| S-EPMC9917446 | biostudies-literature
| S-EPMC3940292 | biostudies-literature
| S-EPMC6722552 | biostudies-literature
| S-EPMC2878340 | biostudies-literature
| S-EPMC8249458 | biostudies-literature
| S-EPMC5442125 | biostudies-literature
| S-EPMC7767524 | biostudies-literature